SMMT vs. MSOS
SMMT (Summit Therapeutics Inc.) is a stock, while MSOS (AdvisorShares Pure US Cannabis ETF) is Small Cap Blend Equities fund actively managed by AdvisorShares. Over the past 5 years, SMMT returned 12.18%/yr vs -34.67%/yr for MSOS. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
SMMT vs. MSOS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -25.56% return, which is significantly lower than MSOS's -10.38% return.
SMMT
- 1D
- -3.12%
- 1M
- -15.56%
- 6M
- -10.08%
- YTD
- -25.56%
- 1Y
- -51.90%
- 3Y*
- 84.00%
- 5Y*
- 12.18%
- 10Y*
- 6.40%
- ALL TIME*
- 2.32%
MSOS
- 1D
- 0.48%
- 1M
- -13.50%
- 6M
- 4.96%
- YTD
- -10.38%
- 1Y
- 37.34%
- 3Y*
- -8.60%
- 5Y*
- -34.67%
- 10Y*
- —
- ALL TIME*
- -26.03%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $13.98M | $19.49M | $31.09M | |
| $58.74M | $54.76M | $76.18M |
SMMT vs. MSOS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -25.56% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 36.23% |
MSOS AdvisorShares Pure US Cannabis ETF | -10.38% | 23.88% | -45.65% | 0.29% | -72.68% | -29.69% | 44.84% |
Correlation
The correlation between SMMT and MSOS is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Sep 2, 2020 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. MSOS — Risk / Return Rank
SMMT
MSOS
SMMT vs. MSOS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and AdvisorShares Pure US Cannabis ETF (MSOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | MSOS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -2.31 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.18 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 0.94 | -1.83 |
| Martin ratioReturn relative to average drawdown | -1.28 | 1.64 | -2.93 |
Loading charts...
Drawdowns
SMMT vs. MSOS - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum MSOS drawdown of -96.25%. Use the drawdown chart below to compare losses from any high point for SMMT and MSOS.
Loading charts...
Drawdown Indicators
| SMMT | MSOS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -96.25% | +0.50% |
Max Drawdown (1Y)Largest decline over 1 year | -57.20% | -52.91% | -4.29% |
Max Drawdown (3Y)Largest decline over 3 years | -65.80% | -81.71% | +15.91% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -94.45% | +2.67% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | — | — |
Current DrawdownCurrent decline from peak | -64.52% | -92.29% | +27.77% |
Average DrawdownAverage peak-to-trough decline | -57.66% | -72.23% | +14.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.51% | 30.20% | +9.31% |
Volatility
SMMT vs. MSOS - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 20.05% compared to AdvisorShares Pure US Cannabis ETF (MSOS) at 13.19%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than MSOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | MSOS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.05% | 13.19% | +6.86% |
Volatility (6M)Calculated over the trailing 6-month period | 56.28% | 56.27% | +0.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.60% | 111.22% | -37.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.17% | 78.34% | +106.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.56% | 73.62% | +70.94% |
Dividends
SMMT vs. MSOS - Dividend Comparison
Neither SMMT nor MSOS has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
MSOS AdvisorShares Pure US Cannabis ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.27% |
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SMMT and MSOS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (20.05%) compared to MSOS (13.19%). In terms of maximum drawdown, SMMT dropped -95.75% vs MSOS's -96.25%.
MSOS currently has the higher Sharpe Ratio (0.45 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and MSOS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer